Literature DB >> 16412864

Physiologic pacing in patients with obstructive sleep apnea: a prospective, randomized crossover trial.

Andrew D Krahn1, Raymond Yee, Mark K Erickson, Toby Markowitz, Lorne J Gula, George J Klein, Allan C Skanes, Charles F P George, Kathleen A Ferguson.   

Abstract

OBJECTIVES: This study was designed to assess the impact of prevention of bradycardia with physiologic pacing on the severity of obstructive sleep apnea.
BACKGROUND: Apneic episodes during sleep are associated with slowing of the heart rate during apnea and tachycardia with subsequent arousal. Patients with permanent pacemakers may have reduced episodes of sleep apnea when their pacemaker rate is set faster than their spontaneous nocturnal heart rate.
METHODS: We conducted a prospective, randomized, single-blind crossover trial of temporary atrial pacing in obstructive sleep apnea to reduce the apnea hypopnea index (AHI). Fifteen patients (age 60 +/- 13 years, 12 men) with moderate to severe obstructive sleep apnea (AHI 34 +/- 14) underwent insertion of an externalized atrial permanent pacing system via the left subclavian vein. Patients underwent overnight respiratory sleep studies in hospital, during atrial pacing at 75 beats/min, and with pacing turned off. The order of pacing mode was randomized, with crossover the subsequent night to the other mode. Patients were blinded to pacing mode, and the analysis of sleep recordings was blind to pacing mode.
RESULTS: Pacing was tolerated without complications in all patients. Overnight physiologic pacing did not affect the AHI (pacing 39 +/- 21/h vs. control 42 +/- 21/h, p = 0.23, 95% confidence interval -9.3 to 2.5 for difference), desaturation time (pacing 3.8 +/- 6.0% vs. control 3.5 +/- 4.3%, p = 0.70), or the minimum SaO(2) (pacing 75 +/- 10% vs. control 77 +/- 11%, p = 0.38). There was a borderline significant reduction in circulatory time with pacing (pacing 23.4 +/- 3.2 s vs. control 25.5 +/- 4.4 s, p = 0.09).
CONCLUSIONS: Temporary atrial pacing does not appear to improve respiratory manifestations of obstructive sleep apnea. Permanent atrial pacing in this patient population does not appear to be justified.

Entities:  

Mesh:

Year:  2005        PMID: 16412864     DOI: 10.1016/j.jacc.2005.09.026

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

Review 1.  Sleep-disordered breathing and cardiovascular disorders.

Authors:  Rohit Budhiraja; Pooja Budhiraja; Stuart F Quan
Journal:  Respir Care       Date:  2010-10       Impact factor: 2.258

Review 2.  Central sleep apnea: Pathophysiology and treatment.

Authors:  Danny J Eckert; Amy S Jordan; Pankaj Merchia; Atul Malhotra
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

3.  Obstructive sleep apnea and cardiac arrhythmias.

Authors:  Ahmad Salah Hersi
Journal:  Ann Thorac Med       Date:  2010-01       Impact factor: 2.219

4.  Sleep-disordered breathing in patients undergoing transfemoral aortic valve implantation for severe aortic stenosis.

Authors:  Zisis Dimitriadis; Marcus Wiemer; Werner Scholtz; Lothar Faber; Cornelia Piper; Thomas Bitter; Ippokratis Messaritakis; Kevin Bullert; Jochen Boergermann; Georg Kleikamp; Christian Prinz; Dieter Horstkotte; Olaf Oldenburg
Journal:  Clin Res Cardiol       Date:  2013-08-21       Impact factor: 5.460

Review 5.  Effect of cardiac pacing on sleep-related breathing disorders: a systematic review.

Authors:  Dimitrios L Anastasopoulos; Athanasios Chalkias; Nicoletta Iakovidou; Theodoros Xanthos
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

6.  Cardiac or Other Implantable Electronic Devices and Sleep-disordered Breathing - Implications for Diagnosis and Therapy.

Authors:  Henrik Fox; Thomas Bitter; Klaus-Jürgen Gutleben; Dieter Horstkotte; Olaf Oldenburg
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30

7.  Diagnosis and treatment of sleep apnea in heart disease.

Authors:  Julio A Barcena; James C Fang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.